United States - English - NLM (National Library of Medicine)

nostrum laboratories, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

United States - English - NLM (National Library of Medicine)

bionpharma inc., - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries limited - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

United States - English - NLM (National Library of Medicine)

monarch pharmaceuticals, inc. - theophylline, anhydrous (unii: 0i55128jyk) (theophylline - unii:c137dtr5rg) - tablet - 300 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. quibron® -t accudose® tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

Canada - English - Health Canada

teva canada limited - theophylline - tablet (extended-release) - 100mg - theophylline 100mg - respiratory smooth muscle relaxants

Canada - English - Health Canada

teva canada limited - theophylline - tablet (extended-release) - 200mg - theophylline 200mg - respiratory smooth muscle relaxants

Canada - English - Health Canada

teva canada limited - theophylline - tablet (extended-release) - 300mg - theophylline 300mg - respiratory smooth muscle relaxants

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - theophylline 100mg;   - modified release capsule - 100 mg - active: theophylline 100mg  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - theophylline 200mg;   - modified release capsule - 200 mg - active: theophylline 200mg  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - theophylline 300mg;   - modified release capsule - 300 mg - active: theophylline 300mg